
To assess the effectiveness and safety of sodium‐glucose cotransporter‐2 (SGLT2) inhibitors in treatment‐naïve patients compared with metformin. We conducted a cohort study of US adults with type 2 diabetes mellitus who had not filled a prescription for a diabetes medication in the preceding year. We then identified patients who newly filled a prescription for an SGLT2 inhibitor or metformin between 2013 and 2018. The primary outcome was a composite of heart failure, myocardial infarction or stroke...
Like
Save
Share